Effects of conjugated fatty acid supplementation on central obesity and blood pressure in women with benign breast disease: a randomized controlled-clinical trial
Effects of conjugated fatty acid supplementation on central obesity and blood pressure in women with benign breast disease: a randomized controlled-clinical trial
نویسندگان: وحید منتظری , بهزاد برادران , سعید پیروزپناه , ندا رضوانی
کلمات کلیدی: Benign breast disease, conjugated fatty acid, central obesity, blood pressure
نشریه: 28307 , 2S , 20 , 2018
| نویسنده ثبت کننده مقاله |
سعید پیروزپناه |
| مرحله جاری مقاله |
تایید نهایی |
| دانشکده/مرکز مربوطه |
دانشکده تغذیه |
| کد مقاله |
65430 |
| عنوان فارسی مقاله |
Effects of conjugated fatty acid supplementation on central obesity and blood pressure in women with benign breast disease: a randomized controlled-clinical trial |
| عنوان لاتین مقاله |
Effects of conjugated fatty acid supplementation on central obesity and blood pressure in women with benign breast disease: a randomized controlled-clinical trial |
| ناشر |
5 |
| آیا مقاله از طرح تحقیقاتی و یا منتورشیپ استخراج شده است؟ |
خیر |
| عنوان نشریه (خارج از لیست فوق) |
|
| نوع مقاله |
Original Article |
| نحوه ایندکس شدن مقاله |
ایندکس شده سطح یک – ISI - Web of Science |
| آدرس لینک مقاله/ همایش در شبکه اینترنت |
|
| Health benefits of conjugated fatty acids, particularly conjugated linolenic acid (CLNA),
have recently provide substantial insights in a variety of obesity-related tumorigenesis including breast neoplasia.
This study aims to investigate the effects of CLNA-contained oil (CLNAO) supplementation on central obesity
indices and blood pressure in women with benign breast disease (BBD). Methods: Forty six pre-menopausal
women with BBD were randomly allocated to intervention group (n=23) or placebo (n=23). Patients in the
intervention group received 1000 mg/day CLNAO capsule and the placebo group received 1000 mg/day inert
oil-contained capsule during 13 weeks. Measures of blood pressure and some anthropometric variables were
performed at the baseline and end of study. Result: Systolic (P<0.01) and diastolic (P<0.05) blood pressures
decreased within CLNAO group on subjects whom were overweight. Normal weight participants who received
placebo showed significant increases in total body fat (P<0.05), waist circumference (P<0.05), and waist circumference
to height ratio (P<0.05), meantime CLNAO group showed no changes on both variables. Intervention
with CLNAO caused no significant increases on skinfolds of abdomen and suprailiac, whereas these measures
were remarkably increased in placebo (P<0.001 and P<0.05, respectively). Conclusion: Findings from this study
show that CLNAO can attenuate development of central fat acquisition in the BBD patients who weighted
normally. Administration of CLNAO decline systolic and diastolic blood pressures of overweight subjects. |
| نام فایل |
تاریخ درج فایل |
اندازه فایل |
دانلود |
| 5708-Article Text-19081-3-10-20181212.pdf | 1397/10/19 | 610286 | دانلود |